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Abstract
Background: Suicide and non-fatal suicidal behaviour are significant public health issues in Europe
requiring effective preventive interventions. However, the evidence for effective preventive
strategies is scarce. The protocol of a European research project to develop an optimized evidence
based program for suicide prevention is presented.
Method: The groundwork for this research has been established by a regional community based
intervention for suicide prevention that focuses on improving awareness and care for depression
performed within the European Alliance Against Depression (EAAD). The EAAD intervention
consists of (1) training sessions and practice support for primary care physicians,(2) public relations
activities and mass media campaigns, (3) training sessions for community facilitators who serve as
gatekeepers for depressed and suicidal persons in the community and treatment and (4) outreach
and support for high risk and self-help groups (e.g. helplines). The intervention has been shown to
be effective in reducing suicidal behaviour in an earlier study, the Nuremberg Alliance Against
Depression. In the context of the current research project described in this paper (OSPI-Europe)
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BMC Public Health 2009, 9:428 http://www.biomedcentral.com/1471-2458/9/428the EAAD model is enhanced by other evidence based interventions and implemented
simultaneously and in standardised way in four regions in Ireland, Portugal, Hungary and Germany.
The enhanced intervention will be evaluated using a prospective controlled design with the primary
outcomes being composite suicidal acts (fatal and non-fatal), and with intermediate outcomes being
the effect of training programs, changes in public attitudes, guideline-consistent media reporting. In
addition an analysis of the economic costs and consequences will be undertaken, while a process
evaluation will monitor implementation of the interventions within the different regions with
varying organisational and healthcare contexts.
Discussion: This multi-centre research seeks to overcome major challenges of field research in
suicide prevention. It pools data from four European regions, considerably increasing the study
sample, which will be close to one million. In addition, the study will gather important information
concerning the potential to transfer this multilevel program to other health care systems. The
results of this research will provide a basis for developing an evidence-based, efficient concept for
suicide prevention for EU-member states.
Background
Public health relevance of suicide in the European Union
Fatal and non-fatal suicide acts are a significant public
health issue. This is especially the case in Europe where
the highest rates for completed suicide in the world are
found [1]. Every year more than 58,000 persons die by
suicide within the European Union. According to World
Health Organization (WHO data), suicide is among the
10 leading causes of death for all ages [2]. Suicidal acts
pose a considerable burden of disease and death. Suicide
needs to be viewed not only as the premature end of a
human life but as affecting and traumatising family mem-
bers and other persons involved. Therefore, in 1984 the
WHO's European Member States defined the reduction of
suicide as one of its main health policy targets and rein-
forced this target in several position papers [3]. In addi-
tion, preventing suicide is one of the five areas of priority
of the European Pact for Mental Health and Well-Being,
which was launched by the European Commission in
2008 [4].
Closely related to completed suicides are non-fatal sui-
cidal acts. The rate of non-fatal suicidal acts is estimated to
be about 10 times higher than that of suicides. Non-fatal
suicidal acts are the strongest predictor for completed sui-
cide, especially in males [5]. Thus, every global strategy to
prevent suicide should also include the prevention of
non-fatal suicidal acts, not only as a goal in itself, but as
an efficient means of preventing completed suicides.
Rates of non-fatal suicidal acts and suicides depend on
many factors. It is estimated that in Europe 90% of sui-
cides occur within the context of a psychiatric disorder [6].
Depression is most commonly associated with suicide,
but other affective disorders, alcohol and substance abuse
disorders, and schizophrenia also frequently underlie sui-
cidal behaviour [7-10]. Yet, suicidality and the transition
from non-lethal to lethal acts are complex phenomena,
complicated by access to lethal means, gender, and cul-
tural and social factors including attitudes towards suicid-
ality, as well as personality factors such as impulsivity.
Because of the multi-factorial nature of suicidality, inter-
ventions that address the problem on multiple levels are
considered to be most effective. However, strong evidence
delineating the most effective strategy to prevent suicidal-
ity and the necessary components of suicide prevention
programs is lacking [6,11].
In the face of the complexity of risk for suicide, and scarce
evidence but nevertheless a high need for on effective sui-
cide prevention on a community level, the European
Commission recently committed to financing a research
project within the seventh Framework Program with the
goal of optimizing suicide prevention programs and their
implementation in Europe (OSPI-Europe).
The aim of OSPI-Europe is to provide diverse regional pol-
icy makers and the European Commission with an evi-
dence based, efficient concept for suicide prevention
along with the corresponding materials and instruments
for the multifaceted intervention and guidelines for the
implementation process.
The specific study objectives include:
1. To develop a state of the art intervention concept for the
prevention of suicidality that considers current evidence
based best practices and international experiences with
multilevel interventions.
2. To implement a multilevel community based interven-
tion in four culturally different European model regions
in a comparable manner.Page 2 of 8
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country comparable design including primary and sec-
ondary outcomes, as well as to perform process and eco-
nomic evaluations.
An outline of the research concept is presented in Figure 1.
Groundwork
The groundwork for the OSPI-Europe project was estab-
lished through a community based multifaceted interven-
tion program for improving care of depression and for
preventing suicidality that was implemented in Nurem-
berg, Germany, a city with a population of 500,000 inhab-
itants (Nuremberg Alliance Against Depression, NAD)
[12]. The Nuremberg intervention approached the pre-
vention of suicide and non-fatal suicidal acts by focusing
not only on improving the treatment of depression but
also by implementing other measures, such as influencing
the media to report suicide in a responsible, non-sensa-
tional and respectful manner. The hypothesis was that
improvement in depression awareness and treatment
would lead to a reduction in suicidal behaviour on a pop-
ulation basis. The NAD comprised a 4-level intervention:
1. Training and practice support for primary care phy-
sicians in detecting and treating depression
2. Public relations activities for informing the general
public about depression, including anti-stigma cam-
paigns.
3. Training sessions on depression and suicidality for
community facilitators such as priests, social workers,
geriatric care givers, teachers and journalists who are
gatekeepers in a position to direct vulnerable and high
risk persons into effective treatment
4. Overtures to high risk groups (persons after non-
fatal suicidal acts), establishment of help lines and
support of self-help activities involving patients and
relatives
The NAD was rigorously evaluated according to a control-
led pre-post design with the number of suicidal acts (fatal
and non-fatal) as primary outcome. After two years of
intervention, a major reduction in the number of suicidal
acts was found compared to the baseline year (-24%, p <
0.005). This reduction was clearly significant compared to
corresponding changes in the control region (Wuerz-
burg). The reduction was even more pronounced (-53%,
p < 0.01) in secondary analyses examining only the five
most lethal suicide attempt methods [13].
The 4-level intervention concept of NAD was further
refined and transferred to other EU countries. Thereby the
European Alliance Against Depression (EAAD) came
together [14-16]. The EAAD was an EU-funded network of
partners from 17 countries that all aimed to implement
the 4-level intervention concept in their regions, adapting
it to local conditions even while preserving what were
viewed as the key components. The strong evidence base,
materials, concepts and evaluation tools of the NAD,
combined with the network and experience of the EAAD
OSPI-Europe Research ConceptFigure 1
OSPI-Europe Research Concept.Page 3 of 8
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from which OSPI-Europe was developed.
Methodological challenges in assessing the effectiveness of 
suicide prevention programs
One of the challenges of field research on suicide preven-
tion is that because of a low base rate in completed sui-
cides, it has been notoriously difficult to provide strong
evidence concerning suicide-preventive effectiveness for
any particular measure (e.g. interventions with high risk
groups, public relations campaigns, etc) [11]. The smaller
the population under observation, the higher the risk to
miss statistically even highly relevant effects on suicide
rates. In order to address this issue OSPI-Europe seeks to
increase statistical power by two approaches: (1) Increas-
ing the size of the population under observation (denom-
inator) by aggregating data from four regions that
implement a similar suicide prevention program, and (2)
increasing the numerator by constructing a composite pri-
mary outcome, consisting of completed suicides but also
non-fatal suicidal acts.
Methods/design
Development of a state of the art intervention concept
Prior to designing the optimal intervention, the literature
was been systematically reviewed and experts in suicidal-
ity research consulted. The criterion for selecting individ-
ual preventive strategies was scientific evidence for4
effectiveness. In addition to evaluating the effects of the
five intervention levels separately, the synergistic effects of
the multifaceted approach will also be taken into account.
The target population, in which suicide is to be prevented,
ranges from adolescence to old age (high rate of suicide in
most countries).
A core element of the state of the art intervention devel-
oped through OSPI-Europe is the EAAD/NAD 4-level
intervention concept and the available materials which
are already in use within the EAAD. There is lower level
evidence available that the individual strategies combined
within the 4-level intervention concept may be effective
[6,11]. However, strong evidence is available showing that
the four-level intervention is effective as a package [13]. In
the context of the research presented here, the original
EAAD four-level intervention is enhanced by the inclu-
sion of additional strategies that have recently demon-
strated a potential for efficacy. Thus, as part of the
optimisation process, efforts to restrict access to lethal
means will comprise a fifth intervention level of OSPI-
Europe. The main focus of the fifth level will include
actions such as working with local councils to install
higher railings at bridges and encouraging the prescrip-
tion of antidepressants that are less likely to be lethal in
overdoses.
Implementation of a multilevel community based 
intervention
The intervention concept developed will be implemented
and tested in regions of four countries (Ireland, Germany,
Hungary, Portugal) in a comparable manner. The coun-
tries were chosen to represent different EU-health systems
and different socio-cultural characteristics as outlined in
Table 1.
It was considered unrealistic to randomly select interven-
tion regions from all EU member states because of the
multiple factors on which representativeness could be
called into question.
Within each of the four model countries, intervention
regions are established. Interventions are implemented in
a standardised and synchronized way to ensure compara-
bility across the regions. This means that interventions
contain the same core elements (defined by minimum
standard of implementation type and intensity) that are
defined as "obligatory interventions" and are imple-
mented in a similar time frame, and in each of the four
regions. In addition "optional interventions" are also
defined. These can be implemented in the regions accord-
ing to local requirements and resources. By distinguishing
between obligatory and optional interventions some
modification and adaptation to local needs in the differ-
ent regions is allowed, but the basic concept is preserved
across intervention sites. The intervention will be imple-
mented in the four regions over a period of at least 18
months, starting in 2009.
Table 1: Main characteristics of intervention countries and intervention and control regions
Country Health System intervention region control region
Hungary Centralised national health insurance fund, limited private sector Miskolc population 180,000 Szeged population 170,000
Ireland Tax funded public health service, with supplemental voluntary 
insurance
Limerick population 184,055 Galway population 231,670
Portugal mix of National Health Service, special social health insurance schemes 
for certain professions and private health insurance
Amadora population 200,000 Almada population 110,000
Germany Bismarckian/social health insurance system with strong public-private 
partnership
Leipzig population 500,000 Magdeburg population 230,000Page 4 of 8
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The intervention is evaluated according to a prospective
and controlled design. Therefore control regions are cho-
sen in each intervention country. Control regions are
comparable to intervention regions in terms of urbanity
(please see Table 1 for further details). Evaluations will be
performed based on primary and intermediate outcomes.
Additionally, a process evaluation and an evaluation of
the economic costs and consequences of the intervention
will be conducted.
Primary and secondary outcomes
The primary outcome for evaluating the effect of the
intervention is the rate of suicidal acts (fatal + non-fatal)
in the intervention and the control regions at baseline (six
months prior to the start of the intervention), during the
18 months of the intervention and six months after. The
main hypothesis is that the number of suicidal acts will
decrease in each intervention region compared to baseline
(six months prior to the start of the intervention) and that
this decrease is significantly stronger than changes
observed in the corresponding control regions.
For the rates of completed suicides in intervention and
control regions, the rates published by the respective sta-
tistical offices are used. Data on non-fatal suicidal acts are
collected in general hospital emergency rooms, where per-
sons after non-fatal suicidal acts seek medical help. Infor-
mation on non-fatal suicidal acts is recorded using the
instrument of the Monitoring Suicidal Behaviour in
Europe (MONSUE) project which is based on the WHO/
Euro Multicentre Study on Suicidal Behaviour [17].
Intermediate outcomes
In order to further measure the effectiveness of the OSPI-
Europe intervention, the study aims to assess intermediate
outcomes associated with the single interventions that
make up the OSPI-Europe intervention package. These
foci on more short term effects are directly linked to the
operational goals and the content of the interventions,
such as improved awareness, knowledge, confidence, and
attitude change.
Prior to the baseline assessment in the four participating
intervention regions, a standard evaluation methodology
for intermediate outcome criteria is developed based on
review of the relevant literature, a review of the existing
EAAD evaluation catalogue and consultation with EAAD I
and EAAD II partners, as well other researchers/experts in
suicide prevention.
The evaluation of intermediate outcomes includes the fol-
lowing factors:
Public attitudes
A population survey on attitudes and knowledge towards
depression and suicidality is performed in the interven-
tion and control regions at baseline and about 12 months
following intervention implementation. The survey is
based on existing validated instruments: the Depression
Stigma Scale (DSS), [18] and the Attitude Toward Seeking
Professional Psychological Help (ATSPPH-SF) question-
naire [19]. Five hundred people sampled from the general
population will complete baseline and follow-up tele-
phone interviews in all intervention and control regions.
These will be conducted by a single independent survey
company to ensure consistency of implementation across
all regions.
Treatment of depression
As a proxy for the treatment of depression, prescription
rates for antidepressants and other psychopharmaceuti-
cals will be monitored in the intervention regions by
using health insurance data or equivalents, available in
the intervention countries.
Training programs
Effects of training for community facilitators and general
practitioners will be evaluated. Evaluation will be based
on questionnaires such as the DSS [18], Suicide Interven-
tion Response Inventory (SIRI-2) [20], confidence scales
[21,22], intervention knowledge test [23], Depression
Attitude Questionnaire (DAQ) [24,25] and the Attitude
Toward Suicide Prevention Scale [26]. Questionnaires will
be tailored to the specific target groups where necessary.
In addition, general practitioners' referral to psychological
treatment will be evaluated, before and after trainings, as
well as at four months follow-up.
Media reporting
Media reports on suicide (such as articles in the local
newspapers) will be collected in the intervention and con-
trol regions. The number (quantitative assessment) and
the content of the reporting (qualitative analyses) will be
compared before and after the intervention. The desired
outcome is media reporting that is in line with WHO and
IASP guidelines for responsible suicide reporting.
Economic evaluation
It is important in a situation where resources are limited
to consider not only if something works, and in what con-
text, but also at what costs. Economic evaluation can help
aid decision makers address this question. It compares the
costs and effectiveness of two or more interventions. Our
hypothesis is that the intervention will lead to reductions
in the numbers of completed suicides and non-fatal sui-
cidal acts; this in turn will be associated with an overall
reduction in the use of resources, such as health care and
emergency services.Page 5 of 8
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of the interventions, firstly the costs of suicide and non-
fatal suicidal acts will be estimated in each of the four
countries. This will be done from both a public purse and
societal perspective. A questionnaire will be developed to
collect information on the typical resource use for suicidal
events, for instance police time inputs and the need for
ongoing treatment and support for non-fatal suicidal acts.
Lifetime productivity losses to the economy due to prema-
ture mortality will be valued using age adjusted average
wage rates. Intangible costs associated with suicide such as
the pain and shock experienced by family members will
be imputed using data on the economic impacts of sud-
den death from road traffic accidents. These data have pre-
viously been used in valuing the costs of suicide in Ireland
and Scotland [27,28].
Secondly, resources, including unpaid volunteer inputs,
required to deliver the intervention will be collated using
expert responses to a modified version of the Client Serv-
ice Receipt Inventory (CSRI) [29]; in addition, this instru-
ment will also gather data on some of the costs associated
with the initial development and implementation of the
OSPI-Europe intervention.
Using this data we will then be able to construct a cost
effectiveness analysis comparing changes in the rate of
suicidal acts in the intervention and control areas with the
costs of delivering the interventions less the costs avoided
as a result of suicides averted. Sensitivity analysis will be
used to test how varying assumptions on costs, effective-
ness and fidelity of implementation impact on the likeli-
hood that the intervention will be cost effective. This will
be demonstrated visually using cost effectiveness accepta-
bility curves. Finally we will also use decision analytical
modelling to help project the long term potential costs
and consequences of the OSPI-intervention of beyond the
duration of our empirical study period.
Evaluation of the implementation process
Data about the actual process of implementation will pro-
vide valuable information about the obstacles encoun-
tered and the fidelity of the implementation in the
intervention regions. Specifically at play are the character-
istics of the local environment which have the potential to
influence both suicidal behaviour and the effective imple-
mentation of a prevention program. Key issues to be con-
sidered beyond prevailing local attitudes toward mental
health treatment (which is assessed also as an intermedi-
ate outcome) and patterns of suicidality, concern local
health care structures and resources, ongoing local actions
or national actions targeting suicidality, and other factors
affecting mental well-being such as unemployment rates.
This contextual information is gathered at both national
and local level and is used to aid comparisons and under-
standing of differences in outcomes between each pair of
intervention and control regions, as well as across the four
interventions sites.
In addition, key stakeholders across all four intervention
sites will be interviewed at six monthly intervals on the
progress in the implementation process using semi-struc-
tured interviews, which will be transcribed and translated
into English. This will include gathering information on
the local context (and any important intervening events)
as well the actual implementation process. This includes
information on whether the intervention will succeed in
involving all necessary stakeholders, information on the
activities that are implemented in the region and the
resources available. Of particular interest is additional
funding/support, that is made available to the local activ-
ities, the barriers and facilitators that have impacted on
the implementation process and the sustainability of the
interventions. The Community Capacity Index (CCI) [30]
will be used to assess the added value for regions in engag-
ing in a multi-level intervention and the sustainability of
local activities. This will compliment more quantitative
outcomes from the OSPI-Europe intervention.
Finally, the number of activities that form part of the
intervention such as public events, leaflets distributed,
training sessions held and self-help groups founded will
be documented in the intervention regions.
Funding and Consortium
The project is funded by the 7th Research Framework Pro-
gram of the European Union for the duration of four
years. The consortium consists of 14 partners, most of
whom took part in EAAD. Therefore, the project will ben-
efit from previously developed working alliances and a
culture of discussion and mutual understanding already
existing in the EAAD.
Ethical principles
The study is planned and will be executed in accordance
with the principles laid down in the Helsinki declaration
(Edinburgh, Scotland amendment, October 2000). The
study protocol was approved both by the Data Protection
Commission of Saxony, Germany and the Medical Ethical
Board of the Leipzig University. In addition the other
study centres in Hungary, Ireland and Portugal are cur-
rently seeking ethical approval from their local authority.
Discussion
OSPI-Europe aims to provide the EU-member states with
realistic evidence-based recommendations and decision-
support regarding the design and implementation of
effective programs to reduce suicidality. The concrete
focus on implementation allows to study the efficiency of
the prevention program, as well as a process evaluation ofPage 6 of 8
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developed materials and instruments, possible shortcom-
ings, potentials for improvement will be identified and
improvements will be made based on lessons learned.
Thereby, the OSPI-Europe project seeks to bridge the gap
between theoretical recommendations and practical
application.
The limitations of the study design originate in the chal-
lenges of simultaneously implementing comparable inter-
ventions in four different countries and health systems.
However, process evaluation will entail the collection of
important information regarding the transferability of the
intervention to different health systems. The close moni-
toring of the implementation process will help to control
and explain differences in implementation that might
occur at the four intervention sites.
The existence of different health care systems may also
complicate evaluation of the intervention. Availability of
health services and specialised mental health care, access
to psychotherapy, as well as requirements for out of
pocket payments for medication and health services differ
in the four intervention countries. Data for antidepressant
prescriptions are available in some countries as health
insurance data (Germany), and in others as IMS (Inter-
continental Marketing Services) data. Close cooperation,
harmonisation of terms and definitions as well as con-
senting on minimum standards within the project consor-
tium are needed to address the challenges with
simultaneous data collection.
Further challenges emerge by conducting research within
real world local environments where it is impossible to
control other intervening activities such as the introduc-
tion of National Suicide Prevention strategies (which may
or may not include specific prevention activities) or other
local initiatives on depression. Other intervention factors,
such as the current economic downturn, which may, for
instance, lead to significant job losses in some study areas,
may also blur the effectiveness of the intervention. Moni-
toring of intermediate effects, as well as precisely docu-
menting environmental conditions prior to and during
the study within intervention and control regions, should
allow for more robust interpretation and understanding
of primary and secondary outcomes.
The strengths of the design relate to its being grounded in
an intervention and evaluation concept that has previ-
ously been shown to be effective [13]. Moreover, the Euro-
pean Alliance Against Depression (EAAD) has
demonstrated that it is possible to implement basic ele-
ments of the OSPI-Europe intervention in different Euro-
pean countries and health systems according to a
standardised procedure [15]. Finally, the OSPI-Europe
consortium is built on the foundations of the EAAD, and
thus draws on the networks, expertise, prior collaboration
and knowledge exchange culture that has been developed
in the different EAAD countries and during EAAD co-
operations since its foundation in 2004.
For OSPI-Europe to make a contribution to suicide pre-
vention in the European Community, OSPI-Europe needs
not only to construct a strong intervention and conduct
high level research, but it also needs to disseminate results
effectively. Dissemination strategies, which are not pre-
sented in detail in the context of this paper, remain a key
component of the project. Strategies tailored to different
audiences can help facilitate the translation of research
results into policies and action. This article is meant to be
a contribution to this dissemination strategy.
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